Numscull, Marsbar and the great Roman, Vespasian III,
Your XBL dreams are very attractive - as follows:
Terrific upside,
Little or no downside,
Sky's the limit,
Sit on your hands unless you're buying.....etc
These sentiments may be valid for the long term - considering that the new material is yet to be fashioned into a marketable stent notwithstanding the confidence in it shown by the giant Meditronic.
So what are your esteemed opinions re the short term? Say, for the next week.
Opening on Monday 20th Feb above 30 cents?
Wouldn't that be around the 52 week high and therefore attract sustained resistance?
Especially from the speculators who are still shaving their fractions per day off high volumes?
So perhaps a relapse to the 25 - 27 cent range is more likely than a confident climb above 30?
Just asking for your (well-informed) opinions.
(Sir) Lunch-a-lot
- Forums
- ASX - By Stock
- XBL
- is it time for biotechs?
XBL
xceed biotechnology ltd